Impact of nanotechnology in breast cancer

Expert Review of Anticancer Therapy

Volumn 9, Issue 8, 2009, Pages 1021-1024

  Haq, Asif I ^a   Zabkiewicz, Catherine ^a   Grange, Philippe ^a   Arya, Manit ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTHRACYCLINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; GONADORELIN; LIPOSOME; MACROGOL; NANOPARTICLE; NANOSHELL; NANOTUBE; PACLITAXEL; POLYMER; QUANTUM DOT; SILICON DIOXIDE; SMALL INTERFERING RNA; TAMOXIFEN; TRASTUZUMAB; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

BIOLOGICAL THERAPY; BREAST BIOPSY; BREAST CANCER; BREAST SELF EXAMINATION; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GENE THERAPY; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER STAGING; CANCER THERAPY; CLINICAL EXAMINATION; CLINICAL TRIAL; DIAGNOSTIC IMAGING; ECHOMAMMOGRAPHY; EDITORIAL; EUROPE; FUNDING; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; JAPAN; LABORATORY DIAGNOSIS; MAMMOGRAPHY; NANOTECHNOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; SENTINEL LYMPH NODE BIOPSY; UNITED KINGDOM; UNITED STATES;

ANIMALS; BREAST NEOPLASMS; CATHETER ABLATION; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEMS; FEMALE; GENE THERAPY; HUMANS; NANOPARTICLES; NANOTECHNOLOGY;

EID: 70350637514     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/ERA.09.72     Document Type: Editorial

References (27)

1. Tanaka T, Decuzzi P, Cristofanilli M et al. Nanotechnology for breast cancer therapy. Biomed. Microdevices 11(1), 49-63 (2009).
2. Yezhelyev MV, Gao X, Xing Y, Al Hajj A, Nie S, O'Regan RM. Emerging use of nanoparticles in diagnosis and treatment of breast cancer. Lancet Oncol. 7(8), 657-667 (2006). (Pubitemid 44143778)
3. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat. Rev. Cancer 5(3), 161-171 (2005).
4. Wang X, Yang L, Chen ZG, Shin DM. Application of nanotechnology in cancer therapy and imaging. CA Cancer J. Clin. 58(2), 97-110 (2008).
5. Jain KK. Applications of nanobiotechnology in clinical diagnostics. Clin. Chem. 53(11), 2002-2009 (2007).
6. Yezhelyev MV, Al Hajj A, Morris C et al. In situ molecular profiling of breast cancer biomarkers with multicolor quantum dots. Adv. Materials 19, 3146-3151 (2007). (Pubitemid 350044451)
7. Xing Y, Chaudry Q, Shen C et al. Bioconjugated quantum dots for multiplexed and quantitative immunohistochemistry. Nat. Protoc. 2(5), 1152-1165 (2007). (Pubitemid 46901294)
8. Xiao Y, Telford WG, Ball JC, Locascio LE, Barker PE. Semiconductor nanocrystal conjugates, FISH and pH. Nat. Methods 2(10), 723 (2005).
9. Song KH, Kim C, Maslov K, Wang LV. Noninvasive in vivo spectroscopic nanorod-contrast photoacoustic mapping of sentinel lymph nodes. Eur.J. Radiol. 70(2), 227-231 (2009).
10. Tada H, Higuchi H, Wanatabe TM, Ohuchi N. In vivo real-time tracking of single quantum dots conjugated with monoclonal anti-HER2 antibody in tumors of mice. Cancer Res. 67(3), 1138-1144 (2007). (Pubitemid 46270771)
11. Artemov D, Mori N, Okollie B, Bhujwalla ZM. MR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles. Magn. Reson. Med. 49(3), 403-408 (2003). (Pubitemid 36262806)
12. Zhou J, Leuschner C, Kumar C, Hormes JF, Soboyejo WO. Sub-cellular accumulation of magnetic nanoparticles in breast tumors and metastases. Biomaterials 27(9), 2001-2008 (2006). (Pubitemid 41759493)
13. Sunderland CJ, Steiert M, Talmadge JE, Derfus AM, Barry SE. Targeted nanoparticles for detecting and treating cancer. Drug Dev. Res. 67, 70-93 (2006). (Pubitemid 43765051)
14. Pan D, Lanza GM, Wickline SA, Caruthers SD. Nanomedicine: perspective and promises with ligand-directed molecular imaging. Eur. J. Radiol. 70(2), 274-285 (2009).
15. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2(12), 751-760 (2007). (Pubitemid 350223348)
16. Zhang L, Gu FX, Chan JM, Wang AZ, Langer RS, Farokhzad OC. Nanoparticles in medicine: therapeutic applications and developments. Clin. Pharmacol. Ther. 83(5), 761-769 (2008). (Pubitemid 351556021)
17. Weng KC, Noble CO, Papahadjopoulos- Sternberg B et al. Targeted tumor cell internalization and imaging of multifunctional quantum dot-conjugated immunoliposomes in vitro and in vivo. Nano. Lett. 8(9), 2851-2857 (2008).
18. Prabha S, Labhasetwar V. Nanoparticle-mediated wild-type p53 gene delivery results in sustained antiproliferative activity in breast cancer cells. Mol. Pharm. 1(3), 211-219 (2004).
19. Urban-Klein B, Werth S, Abuharbeid S, Czubayko F, Aigner A. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo. Gene Ther. 12(5), 461-466 (2005). (Pubitemid 40394299)
20. Hirsch LR, Stafford RJ, Bankson JA et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc. Natl Acad. Sci. USA 100(23), 13549-13554 (2003).
21. Shao N, Lu S, Wickstromand E, Panchapakesan B. Integrated molecular targeting of IGF1R and HER2 surface receptors and destruction of breast cancer cells using single wall carbon nanotubes. Nanotechnology 18, 315101 (2007).
22. NICE. Advanced breast cancer: diagnosis and treatment www.nice.org.uk
23. Cancer incidence and mortality: trends in the UK and constituent countries www.statistics.gov.uk
24. Cancer research UK www.cancerresearchuk.org
25. NICE. Early and locally advanced breast cancer: diagnosis and treatment www.nice.org.uk
26. Technology Transfer Centre. Government funding, companies and applications in nanotechnology worldwide www.nano.org.uk/reports.htm
27. National Cancer Institute www.cancer.gov